NCT00439855已完成4 期
Enoxaparin Versus Unfractionated Heparin in PCI
适应症
相关药物
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 2,100
- 试验地点
- 2
- 主要终点
- Quadruple endpoint: death, MI, urgent TVR, major bleeding
研究概览
简要总结
Enoxaparin 0.75mg/kg BW is not inferior to weight adjusted unfractionated heparin as anticoagulation for PCI
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •PCI for stable ischemia or ACS
排除标准
- •Cardiogenic shock,
- •Pretreatment with study drugs,
- •Lack of informed consent
结局指标
主要结局
Quadruple endpoint: death, MI, urgent TVR, major bleeding
次要结局
- major bleeding, minor bleeding, thrombocytopenia
研究者
研究点 (2)
Loading locations...
相似试验
招募中
不适用
Difference between Heparin and Enoxaparin on inflammatory biomarkers in the treatment of heart attack (myocardial infarction).inflammatory cytokinCardiovascular - Coronary heart diseaseInflammatory and Immune System - Other inflammatory or immune system disordersSTEMIACTRN12611001139965Tehran university of medical science30
已完成
4 期
Assessment of Cardioversion Using Transesophageal Echocardiography II (ACUTE II)Atrial FibrillationNCT00289042The Cleveland Clinic200
已完成
3 期
Safety and usefulness of Enoxaparin versus unfractionated heparin in patients with ST elevation myocardial infarctioIschaemic heart diseases.Acute myocardial infarctionIRCT138711271695N1Tehran University of Medical Sciences and Health Services150
已完成
1 期
Enoxaparin Bioequivalence Study in Acute Coronary Syndrome PatientsAcute Coronary SyndromeNCT04552067University of Monastir172
已完成
1 期
Enoxamed Study in the Treatment of Acute Coronary SyndromesAcute Coronary SyndromeNCT02152423University of Monastir50